Eloxx Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eloxx pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eloxx Pharmaceuticals Company Profile Today - Breaking & Trending Today

Eloxx Pharmaceuticals (NASDAQ:ELOX) PT Raised to $55.00

Eloxx Pharmaceuticals (NASDAQ:ELOX) PT Raised to $55.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Eloxx Pharmaceuticals Price Performance , Institutional Investors Weigh In On Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Company Profile , Securities Exchange Commission , America Corp , Eloxx Pharmaceuticals Inc , Eloxx Pharmaceuticals , Get Free Report , Free Report , Eloxx Pharmaceuticals Daily ,

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Down 42.8% in June

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 39,000 shares, a decline of 42.8% from the May 31st total of 68,200 shares. Based on an average daily trading volume, of 483,000 shares, […] ....

Eloxx Pharmaceuticals Company Profile , Renaissance Technologies , Hedge Funds Weigh In On Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Inc , Exchange Commission , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Stock , Free Report , Eloxx Pharmaceuticals Daily ,

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, a growth of 320.8% from the March 31st total of 49,000 shares. Currently, 14.1% of the company’s shares are short sold. Based on an average […] ....

United States , America Corp , Hedge Funds Weigh In On Eloxx Pharmaceuticals , News Ratings For Eloxx Pharmaceuticals Daily , Eloxx Pharmaceuticals Stock Performance , Eloxx Pharmaceuticals Company Profile , Eloxx Pharmaceuticals , Exchange Commission , Eloxx Pharmaceuticals Inc , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals (ELOX) Set to Announce Earnings on Friday

Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) is scheduled to be issuing its quarterly earnings data on Friday, March 31st. Eloxx Pharmaceuticals Price Performance Shares of Eloxx Pharmaceuticals stock traded down $0.12 during trading hours on Thursday, reaching $2.35. The company’s stock had a trading volume of 673 shares, compared to its average volume of 128,304. […] ....

Earnings History For Eloxx Pharmaceuticals , Exchange Commission , Eloxx Pharmaceuticals Inc , Renaissance Technologies , Eloxx Pharmaceuticals Company Profile , Hedge Funds Weigh In On Eloxx Pharmaceuticals , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Price Performance , News Ratings For Eloxx Pharmaceuticals Daily , Get Rating , Eloxx Pharmaceuticals Daily , Nasdaq Elox ,

Eloxx Pharmaceuticals (NASDAQ:ELOX) Price Target Cut to $3.00 by Analysts at B. Riley

Eloxx Pharmaceuticals (NASDAQ:ELOX) Price Target Cut to $3.00 by Analysts at B. Riley
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Thomson Reuter , Daniele Geffken , Geode Capital Management , Analyst Recommendations For Eloxx Pharmaceuticals , Eloxx Pharmaceuticals , Zacks Investment Research , Deutsche Bank , Eloxx Pharmaceuticals Inc , Vanguard Group Inc , Topco Ltd , Eloxx Pharmaceuticals Company Profile , Investment Research , Capital Management ,